Yuki Teramoto

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Radical Prostatectomy

Fine Needle Aspiration

Top Venues

International journal of molecular sciences

Pathology international

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Teramoto, Mohammad Amin Elahi Najafi, Takuo Matsukawa, Adhya Sharma, Takuro Goto, Hiroshi Miyamoto
Latrophilins as Downstream Effectors of Androgen Receptors including a Splice Variant, AR-V7, Induce Prostate Cancer Progression. International journal of molecular sciences 25 (13) (2024)
Yuki Teramoto, Mohammad Amin Elahi Najafi, Takuo Matsukawa, Adhya Sharma, Takuro Goto, Hiroshi Miyamoto
Latrophilins as Downstream Effectors of Androgen Receptors including a Splice Variant, AR-V7, Induce Prostate Cancer Progression. International journal of molecular sciences 25 (13) (2024)
Negar Khazan, Emily R Quarato, Niloy A Singh, Cameron W A Snyder, Taylor Moore, John P Miller, Masato Yasui, Yuki Teramoto, Takuro Goto, Sabeeha Reshi, Jennifer Hong, Naixin Zhang, Diya Pandey, Priyanka Srivastava, Alexandra Morell, Hiroki Kawano, Yuko Kawano, Thomas Conley, Deepak M Sahasrabudhe, Naohiro Yano, Hiroshi Miyamoto, Omar Aljitawi, Jane Liesveld, Michael W Becker, Laura M Calvi, Alexander S Zhovmer, Erdem D Tabdanov, Nikolay V Dokholyan, David C Linehan, Jeanne N Hansen, Scott A Gerber, Ashoke Sharon, Manoj K Khera, Peter W Jurutka, Natacha Rochel, Kyu Kwang Kim, Rachael B Rowswell-Turner, Rakesh K Singh, Richard G Moore
Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1. Cancers 15 (13) (2023)
Yuki Teramoto, Numbereye Numbere, Hiroshi Miyamoto
Clinical impact of perineural cancer invasion detected in prostate cores: Involvement of spatially contiguous versus separate biopsy sites. Pathology international (2023)
Mohammad Amin Elahi Najafi, Masato Yasui, Yuki Teramoto, Tomoyuki Tatenuma, Guiyang Jiang, Hiroshi Miyamoto
GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. International journal of molecular sciences 24 (18) (2023)